MUMBAI, India, July 7 -- Intellectual Property India has published a patent application (202421105173 A) filed by Anand Pharmacy College on December 31, 2024, for An Inhalation Formulation Of Rifampicin And Quercetin Nanoparticles.
Inventors include Tandel Devang; Patel Kalpana; Thakkar Vaishali; and Gandhi Tejal.
The application for the patent was published on July 03, 2026, under issue no. 27/2026.
Abstract: ABSTRACT AN INHALATION FORMULATION OF RIFAMPICIN AND QUERCETIN NANOPARTICLES The present invention is related to an inhalation formulation of rifampicin and quercetin nanoparticles comprising nanoparticles of rifampicin and nanoparticles of quercetin. The present invention provides a nanoparticulate inhaler formulation of Rifampicin and quercetin with enhanced dissolution and bioavailability of Rifampicin. The present invention is also related to a nanoparticulate inhaler formulation of rifampicin and quercetin and process of preparing the same.
Disclaimer: Curated by HT Syndication.
